Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus

Table 4

Determinant factors for the efficacy of tofogliflozin in multivariate analyses.

Explanatory variables	Objective variable	β
(Model 1)
Baseline HbA1c	Δ HbA1c (4 weeks)	0.582	<0.01
Baseline VFA		−0.092	n.s.
Age		−0.178	n.s.
(Model 2)
Baseline HbA1c	Δ HbA1c (4 weeks)	0.647	<0.01
Baseline VFA		−0.076	n.s.
Duration		−0.379	<0.01
(Model 3)
Baseline HbA1c	Δ HbA1c (12 weeks)	0.566	<0.01
Baseline VFA		0.112	n.s.
Age		−0.193	n.s.
(Model 4)
Baseline HbA1c	Δ HbA1c (12 weeks)	0.624	<0.01
Baseline VFA		0.126	n.s.
Duration		−0.307	<0.05